A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Assessment of the psychometric properties of the traditional Chinese version of the cancer survivors' self-efficacy scale. | LitMetric

AI Article Synopsis

  • The study aimed to evaluate the reliability and validity of the Traditional Chinese version of the Cancer Survivors' Self-Efficacy Scale (CS-SES-TC) among 300 genitourinary cancer survivors in Taiwan.
  • Results from confirmatory factor analysis (CFA) confirmed that the CS-SES-TC is a unidimensional scale and showed strong psychometric properties, including high factor loadings (above 0.6) and good goodness-of-fit metrics.
  • The scale demonstrated concurrent and discriminant validity, along with a high reliability score (Cronbach's α between .97 and .98), making it a useful tool for healthcare providers to assess cancer survivors' self-efficacy.

Article Abstract

Background: The reliability and validity of the traditional Chinese version of the Cancer Survivors' Self-Efficacy Scale (CS-SES-TC) has not been assessed.

Objective: To assess the psychometric properties of the Traditional Chinese version of the CS-SES-TC.

Methods: Participants were recruited from the outpatient departments of a hospital in Taiwan. A single questionnaire was administered to 300 genitourinary cancer survivors. The scales included in the initial questionnaire were the CS-SES-TC, the General Self-Efficacy Scale, the Center for Epidemiologic Studies Depression Scale (CES-D), and the Functional Assessment of Cancer Therapy-General scale (FACT-G). Data obtained from 300 survivors were used to confirm the structure through confirmatory factor analysis (CFA).

Results: The CFA results indicate that the 11-item CS-SES-TC is consistent with the original scale. Furthermore, it was identified as a unidimensional scale, with the model showing acceptable goodness-of-fit (CFI = 0.99, TLI = 0.97). The factor loading of each item in the CS-SES-TC was above 0.6 and had convergent validity. Based on multiple-group CFA testing, the change (ΔCFI) between the unconstrained and constrained models was ≤ 0.01, indicating that measurement invariance holds for gender. The participants' CS-SES-TC scores were positively correlated with their FACT-G scores and negatively correlated with their CES-D scores. The scales exhibited concurrent validity and discriminant validity. The CS-SES-TC had a Cronbach's α in the range of .97-.98.

Conclusion: The CS-SES-TC had acceptable reliability and validity. Healthcare workers can use this scale for ongoing assessment of the cancer-related self-efficacy of cancer survivors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11343950PMC
http://dx.doi.org/10.1186/s41155-024-00317-yDOI Listing

Publication Analysis

Top Keywords

traditional chinese
12
chinese version
12
self-efficacy scale
12
psychometric properties
8
properties traditional
8
version cancer
8
cancer survivors'
8
survivors' self-efficacy
8
scale
8
reliability validity
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!